Showing all 3 results
Dabigatran Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Tartaric Acid-Cored Pellet Formulation, packed exclusively in highly specialized, moisture-blocking Alu-Alu blister strips with integrated desiccants to ensure the absolute chemical survival of the intensely hygroscopic prodrug.
Active Ingredient Strength Primary Clinical Function Dabigatran Etexilate Mesylate USP/Ph.Eur. 75 mg / 110 mg The Renal & Geriatric Anchor: The strictly mandated dose reductions utilized for elderly patients (over 80 years old), patients with moderate renal impairment, or those at an elevated risk of hemorrhagic bleeding. Dabigatran Etexilate Mesylate USP/Ph.Eur. 150 mg The Cardiovascular Macrodose: The massive, globally standardized therapeutic payload required for the aggressive, daily prevention of stroke and systemic embolism in Non-Valvular Atrial Fibrillation (NVAF). Excipients Tartaric Acid (Core) / Hypromellose / Talc / Hydroxypropyl Cellulose / Dimethicone Acidic Microenvironment Generator / Polymer Binder / Glidant / Film-Coating (Engineered specifically utilizing advanced Fluid-Bed Pellet Coating. The tartaric acid core is isolated with a polymer layer, then coated with the Dabigatran API, and sealed again. This prevents the acid from prematurely degrading the drug before it reaches the patient’s stomach) *Pack Sizes: 10×10 Specialized Alu-Alu Blisters or Heavy-Gauge HDPE Bottles with Desiccant Caps (Optimized specifically for absolute moisture defense).
Heparin Sodium Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Solution in Glass Vials.
Active Ingredient Strength Volume Heparin Sodium USP/BP 5,000 IU (1,000 IU/ml) 5 ml Multi-Dose Vial Heparin Sodium USP/BP 25,000 IU (5,000 IU/ml) 5 ml Multi-Dose Vial Preservative Benzyl Alcohol 0.95% v/v *Available in preservative-free versions for neonatal use upon request.
Nicoumalone Tablet
FreeProduct Composition & Calibration Spectrum
We manufacture Nicoumalone in a complete, highly precise range of strengths to allow for the exact dosage adjustments required to maintain narrow therapeutic targets.
Active Ingredient Common Name Compendial Monograph Available Strengths Primary Clinical Application Nicoumalone (Acenocoumarol) BP / IP / USP 1 mg Micro-Titration Phase: For delicate, low-dose fine-tuning in geriatric or sensitive patient profiles. Nicoumalone (Acenocoumarol) BP / IP / USP 2 mg Foundational Maintenance: The standard baseline dose for routine daily thromboembolic prophylaxis. Nicoumalone (Acenocoumarol) BP / IP / USP 3 mg Intermediate Control: For patients requiring step-up adjustment to hit targeted coagulation thresholds. Nicoumalone (Acenocoumarol) BP / IP / USP 4 mg High-Threshold Suppression: For rapid oral loading or patients presenting high chemical resistance to standard doses.
